Logo image of ALGM

ALLEGRO MICROSYSTEMS INC (ALGM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALGM - US01749D1054 - Common Stock

28.54 USD
-0.21 (-0.73%)
Last: 12/9/2025, 10:10:44 AM
Fundamental Rating

4

ALGM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While ALGM seems to be doing ok healthwise, there are quite some concerns on its profitability. ALGM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGM was profitable.
In the past year ALGM had a positive cash flow from operations.
ALGM had positive earnings in 4 of the past 5 years.
In the past 5 years ALGM always reported a positive cash flow from operatings.
ALGM Yearly Net Income VS EBIT VS OCF VS FCFALGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.05%, ALGM is doing worse than 60.71% of the companies in the same industry.
The Return On Equity of ALGM (-3.00%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROIC N/A
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ALGM Yearly ROA, ROE, ROICALGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

Looking at the Gross Margin, with a value of 44.61%, ALGM is in line with its industry, outperforming 51.79% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGM has grown nicely.
The Profit Margin and Operating Margin are not available for ALGM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
ALGM Yearly Profit, Operating, Gross MarginsALGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

6

2. Health

2.1 Basic Checks

ALGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGM has less shares outstanding
ALGM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALGM is higher compared to a year ago.
ALGM Yearly Shares OutstandingALGM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALGM Yearly Total Debt VS Total AssetsALGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 8.04 indicates that ALGM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.04, ALGM is in the better half of the industry, outperforming 66.96% of the companies in the same industry.
The Debt to FCF ratio of ALGM is 5.05, which is a neutral value as it means it would take ALGM, 5.05 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.05, ALGM perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that ALGM is not too dependend on debt financing.
ALGM has a Debt to Equity ratio of 0.30. This is comparable to the rest of the industry: ALGM outperforms 41.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Altman-Z 8.04
ROIC/WACCN/A
WACC10.48%
ALGM Yearly LT Debt VS Equity VS FCFALGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.89 indicates that ALGM has no problem at all paying its short term obligations.
ALGM has a Current ratio of 3.89. This is in the better half of the industry: ALGM outperforms 62.50% of its industry peers.
ALGM has a Quick Ratio of 2.48. This indicates that ALGM is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALGM (2.48) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 2.48
ALGM Yearly Current Assets VS Current LiabilitesALGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

ALGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.53%.
ALGM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -32.49% yearly.
Looking at the last year, ALGM shows a decrease in Revenue. The Revenue has decreased by -7.23% in the last year.
ALGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%

3.2 Future

Based on estimates for the next years, ALGM will show a very strong growth in Earnings Per Share. The EPS will grow by 87.41% on average per year.
Based on estimates for the next years, ALGM will show a quite strong growth in Revenue. The Revenue will grow by 19.38% on average per year.
EPS Next Y123.02%
EPS Next 2Y103.27%
EPS Next 3Y87.41%
EPS Next 5YN/A
Revenue Next Year20.87%
Revenue Next 2Y19.21%
Revenue Next 3Y19.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALGM Yearly Revenue VS EstimatesALGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ALGM Yearly EPS VS EstimatesALGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 81.54 indicates a quite expensive valuation of ALGM.
The rest of the industry has a similar Price/Earnings ratio as ALGM.
When comparing the Price/Earnings ratio of ALGM to the average of the S&P500 Index (26.34), we can say ALGM is valued expensively.
ALGM is valuated quite expensively with a Price/Forward Earnings ratio of 28.78.
62.50% of the companies in the same industry are more expensive than ALGM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALGM to the average of the S&P500 Index (23.56), we can say ALGM is valued slightly more expensively.
Industry RankSector Rank
PE 81.54
Fwd PE 28.78
ALGM Price Earnings VS Forward Price EarningsALGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALGM.
ALGM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 92.82
EV/EBITDA 98.32
ALGM Per share dataALGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALGM's earnings are expected to grow with 87.41% in the coming years.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y103.27%
EPS Next 3Y87.41%

0

5. Dividend

5.1 Amount

No dividends for ALGM!.
Industry RankSector Rank
Dividend Yield N/A

ALLEGRO MICROSYSTEMS INC

NASDAQ:ALGM (12/9/2025, 10:10:44 AM)

28.54

-0.21 (-0.73%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)01-28 2026-01-28/bmo
Inst Owners75.12%
Inst Owner Change-6.37%
Ins Owners0.66%
Ins Owner Change0.14%
Market Cap5.28B
Revenue(TTM)788.39M
Net Income(TTM)-28.37M
Analysts83.33
Price Target39.35 (37.88%)
Short Float %7.99%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.13%
Max EPS beat(2)5.14%
EPS beat(4)4
Avg EPS beat(4)7.84%
Min EPS beat(4)3.13%
Max EPS beat(4)17.65%
EPS beat(8)8
Avg EPS beat(8)15.73%
EPS beat(12)12
Avg EPS beat(12)11.98%
EPS beat(16)16
Avg EPS beat(16)10.58%
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-1.08%
Max Revenue beat(4)2.03%
Revenue beat(8)3
Avg Revenue beat(8)-0.39%
Revenue beat(12)3
Avg Revenue beat(12)-0.55%
Revenue beat(16)6
Avg Revenue beat(16)-0.1%
PT rev (1m)4.99%
PT rev (3m)0.43%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)3.62%
EPS NY rev (1m)0.8%
EPS NY rev (3m)0.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.93%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 81.54
Fwd PE 28.78
P/S 6.7
P/FCF 92.82
P/OCF 56.12
P/B 5.6
P/tB 10.79
EV/EBITDA 98.32
EPS(TTM)0.35
EY1.23%
EPS(NY)0.99
Fwd EY3.47%
FCF(TTM)0.31
FCFY1.08%
OCF(TTM)0.51
OCFY1.78%
SpS4.26
BVpS5.1
TBVpS2.65
PEG (NY)0.66
PEG (5Y)N/A
Graham Number6.34
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.61%
FCFM 7.22%
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Debt/EBITDA 5.12
Cap/Depr 57.39%
Cap/Sales 4.72%
Interest Coverage N/A
Cash Conversion 168.55%
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 2.48
Altman-Z 8.04
F-Score3
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)131.89%
Cap/Depr(5y)124.81%
Cap/Sales(3y)8.59%
Cap/Sales(5y)8.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y123.02%
EPS Next 2Y103.27%
EPS Next 3Y87.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%
Revenue Next Year20.87%
Revenue Next 2Y19.21%
Revenue Next 3Y19.38%
Revenue Next 5YN/A
EBIT growth 1Y-113.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.32%
EBIT Next 3Y86.13%
EBIT Next 5YN/A
FCF growth 1Y-26.17%
FCF growth 3Y-37.77%
FCF growth 5Y-10.31%
OCF growth 1Y-52.4%
OCF growth 3Y-26.53%
OCF growth 5Y-5.33%

ALLEGRO MICROSYSTEMS INC / ALGM FAQ

What is the ChartMill fundamental rating of ALLEGRO MICROSYSTEMS INC (ALGM) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGM.


Can you provide the valuation status for ALLEGRO MICROSYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to ALLEGRO MICROSYSTEMS INC (ALGM). This can be considered as Fairly Valued.


How profitable is ALLEGRO MICROSYSTEMS INC (ALGM) stock?

ALLEGRO MICROSYSTEMS INC (ALGM) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ALLEGRO MICROSYSTEMS INC (ALGM) stock?

The Price/Earnings (PE) ratio for ALLEGRO MICROSYSTEMS INC (ALGM) is 81.54 and the Price/Book (PB) ratio is 5.6.


What is the expected EPS growth for ALLEGRO MICROSYSTEMS INC (ALGM) stock?

The Earnings per Share (EPS) of ALLEGRO MICROSYSTEMS INC (ALGM) is expected to grow by 123.02% in the next year.